Skip to main content

Endorphins and Affective Illness

  • Chapter

Abstract

The discovery of specific opiate receptors (Simon et al., 1973; Pert and Snyder, 1973) and the identification of naturally occurring peptides possessing opiatelike activity (endorphins) (Hughes et al., 1975; Li and Chung, 1976; Li et al., 1976; Bradbury et al., 1976; Chrétien et al., 1976) have led to considerable research and speculation regarding the relationship of the endorphin system to psychiatric illness (Usdin et al., 1979; Verebey et al., 1978). The mood-altering and calming effects of exogenous opiates (Jaffe and Martin, 1975), the regional brain distribution of opiate receptors (Goldstein, 1976; Goldstein and Cox, 1977), and the behavioral effects of administered endorphins to rats (Bloom et al., 1976) suggested potential relationships between the endogenous opioid systems and emotional behavior. Although initial endorphin-behavioral hypotheses focused on etiologic relevance to schizophrenia (Bloom et al., 1976; Segal et al., 1977), alterations in endorphin function have been hypothesized to be reflected in disorders of mood (Byck, 1976; Belluzzi and Stein, 1977; Gold and Byck, 1978).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ambinder, R. F., and Schuster, M. M., 1979, Endorphins: New gut peptides with a familiarface, Gastroenterology 77:1132.

    Google Scholar 

  • Angst, J., Autenrieth, V., Brem, F., Koukkou, M., Meyer, H., Stassen, H. H., and Storck, U., 1979, Preliminary results of treatment with ß-endorphin in depression, in: Endorphins in Mental Health Research ( E. Usdin, W. E. Bunney, Jr., and N. S. Kline), pp. 518–528, Macmillan Co., New York.

    Google Scholar 

  • Belluzzi, J. D., and Stein, L., 1977, Enkephalin may mediate euphoria and drive reward, Nature (London) 266: 556.

    Article  Google Scholar 

  • Bloom, F., Segal, D., Ling, N., and Guillemin, R., 1976, Endorphins: Profound behavioral effects in rats suggest new etiological factors in mental illness, Science 194: 630.

    Article  Google Scholar 

  • Bloom, F., Bayon, A., Battenberg, E., French, E., Koda, L., Koob, G., Le Moal, M., Rossier, J., and Schoemaker, W., 1980, Endorphins: Developmental, cellular and behavioral aspects, in: Neural Peptides and Neuronal Communication (E. Costa and M. Trabucchi, eds.)., Advances in Biochemical Psychopharmacology, Vol. 22, pp. 619–632, Raven Press, New York.

    Google Scholar 

  • Boyd, A. E., 3rd, and Reichlin, S., 1978, Neural control of prolactin secretion in man, Psychoneuroendocrinology 3: 113.

    Article  Google Scholar 

  • Bradbury, A. F., Smyth, D. G., and Snell, C. R., 1976, Lipotropin: Precursor to two biologically active peptides, Biochem. Biophys. Res. Commun. 69: 950.

    Article  Google Scholar 

  • Brown, W. A., and Shuey, I., 1980, Response to dexamethasone and subtype of depression, Arch. Gen. Psychiatry 37: 747.

    Article  Google Scholar 

  • Bruni, J. F., Van Vugt, D., Marshall, S., and Meites, J., 1977, Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone, Life Sci. 21: 461.

    Article  Google Scholar 

  • Bucknill, J. D., and Tuke, D. H., 1858, Manual of Psychological Medicine, Philadelphia. Bunney, W. E., Jr., and Hamburg, D. A., 1963, Methods for reliable longitudinal observation of behavior, Arch. Gen. Psychiatry 9: 280.

    Google Scholar 

  • Byck, R., 1976, Peptide transmitters: A unifying hypothesis for euphoria, respiration, sleep and the action of lithium, Lancet 2: 72.

    Article  Google Scholar 

  • Carroll, B. J., Curtis, G. C., and Mendels, J., 1976a, Neuroendocrine regulation in depres- sion I. Limbic system–adrenocortical dysfunction, Arch. Gen. Psychiatry 33: 1039.

    Article  Google Scholar 

  • Carroll, B. J., Curtis, G. C., and Mendels, J., 1976b, Neuroendocrine regulation in depression II. Discrimination of depressed from non-depressed patients Arch. Gen. Psychiatry 33: 1051.

    Article  Google Scholar 

  • Chrétien, M., Benjannet, S., Dragon, N., Seidah, N. G., and Lis, M., 1976, Isolation of peptides with opiate activity from sheep and human pituitaries: Relationship to betalipotropin, Biochem. Biophys. Res. Commun. 72: 472.

    Article  Google Scholar 

  • Comfort, A., 1977, Morphine as an antipsychotic. Relevance of a 19th century therapeutic fashion, Lancet 2: 448.

    Article  Google Scholar 

  • Davis, G. C., Bunney, W. E., Jr., DeFraites, E. G., Kleinman, J. E., van Kammen, D. P., Post, R. M., and Wyatt, R. J., 1977, Intravenous naloxone administration in schizophrenia and affective illness, Science 197: 74.

    Article  Google Scholar 

  • Davis, G. C., Bunney, W. E., Jr., Buchsbaum, M. S., DeFraites, E. G., Duncan, W., Gillin, J. C., van Kammen, D. P., Kleinman, J., Murphy, D. L., Post, R. M., Reus, V., and Wyatt, R. J., 1979, Use of narcotic antagonists to study the role of endorphins in normal and psychiatric patients, in Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.)pp. 393-406, Macmillan Co., New York.

    Google Scholar 

  • Davis, G. C., Extein, I., Reus, V., Hamilton, W., Post, R. M., Goodwin, F. K., and Bunney, W. E., Jr., 1980, Failure of naloxone to reduce manic symptoms, Am. J. Psychiatry 137: 1586.

    Google Scholar 

  • Emrich, H. M., Höllt, V., Kissling, W., Fischler, M., Laspe, H., Heinemann, H., von Zerssen, D., and Herz, A., 1979, ß-Endorphin-like immunoreactivity in cerebrospinal fluid and plasma of patients with schizophrenia and other neuropsychiatric disorders, Pharmakopsychiatr. Neuro-Psychopharmakol. 12: 269.

    Google Scholar 

  • Engel, G. L., 1975, Psychophysiological gastrointestinal disorders II. Intestinal disorders, in Comprehensive Textbook of Psychiatry ( A. M. Freedman, H. I. Kaplan, and B. J. Sadock, eds.), Vol. 2, pp. 1643–1648, Williams & Wilkins, Baltimore.

    Google Scholar 

  • Enjalbert, A., Ruberg, M., Arancibia, S., Priam, M., and Kordon, C., 1979, Endogenous opiates block dopamine inhibition of prolactin secretion in vitro, Nature (London) 280: 595.

    Article  Google Scholar 

  • Extein, I., Goodwin, F. K., Lew y, A. J., Schoenfeld, R. I., Fakhuri, L. R., Gold, M. S., and Redmond, D. E., Jr., 1979a, Behavioral and biochemical effects of FK 33–824, a parenterally and orally active enkephalin analogue, in: Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 279-292, Macmillan Co., New York.

    Google Scholar 

  • Extein, I., Pickar, D., Gold, P. W., Gold, M. S., Pottash, A. L. C., Sweeney, D. R., Ross, R. J., Rebar, R., Martin, D., and Goodwin, F. K., 1979b, Methadone and morphine in depression, Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico.

    Google Scholar 

  • Extein, I., Pottash, A. L. C., Gold. M. S., Sweeney, D. R., Martin, D. M., and Goodwin, F. K., 1980, Deficient prolactin response to morphine in depressed patients, Am. J. Psychiatry 137: 845.

    Google Scholar 

  • Fink, M., Simeon, J., Itil, T. M., and Freedman, A. M., 1970, Clinical antidepressant activity of cyclazocine—a narcotic antagonist, Clin. Pharmacol. Ther. 11: 41.

    Google Scholar 

  • Foley, K. M., Kourides, C. E., Inturrisi, C. E., Kaiko, R. F., Zaroulis, C. G., Posner, J. B., Houde, R. W., and Li, C. H., 1979, ß-Endorphin: Analgesic and hormonal effects in humans, Proc. Natl. Acad. Sci. USA 76: 5377.

    Article  Google Scholar 

  • Gerner, R. H., Catlin, D. H., Gorelick, D. A., Hui, K. K., and Li, C. H., 1980, Betaendorphin: Intravenous infusion causes behavioral change in psychiatric inpatients, Arch. Gen. Psychiatry 37: 642.

    Article  Google Scholar 

  • Gold, M. S., and Byck, R., 1978, Endorphins, Lithium, and naloxone: Their relationship to pathological and drug-induced manic-euphoric states, in The International Challenge of Drug Abuse (R. C. Peterson, ed.), National Institute on Drug Abuse Research Monograph Series 19, pp. 192–209, DHEW, Washington, D.C.

    Google Scholar 

  • Gold, M. S., Donabedian, R. K., Dillard, M., Slobetz, F. W., Riordan, C. E., and Kleber, H. D., 1977, Antipsychotic effect of opiate agonists, Lancet 2: 398.

    Article  Google Scholar 

  • Gold, M. S., Redmond, D. E., Jr., Donabedian, R. K., Goodwin, F. K., and Extein, I., 1978a, Increase in serum prolactin by exogenous and endogenous opiates: Evidence for antidopamine and antipsychotic effects, Am. J. Psychiatry. 135: 1415.

    Google Scholar 

  • Gold, M. S., Redmond, D. E., Jr., and Kleber, H. D., 1978b, Clonidine blocks acute opiate-withdrawal symptoms, Lancet 2: 599.

    Article  Google Scholar 

  • Gold, M. S., Pottash, A. L. C., Sweeney, D. R., Kleber, H. D., and Redmond, D. E., Jr., 1979a, Rapid opiate detoxification: Clinical evidence of antidepressant and antipanic effects of opiates, Am. J. Psychiatry. 136: 982.

    Google Scholar 

  • Gold, M. S., Redmond, D. E., Jr., and Kleber, H. D., 1979b, Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal, Am. J. Psychiatry. 136: 100.

    Google Scholar 

  • Gold, P. W., Extein, I., Pickar, D., Rebar, R., Ross, R., and Goodwin, F. K., 1980, Suppression of plasma cortisol in depressed patients by acute intravenous methadone infusion, Am. J. Psychiatry. 137: 862.

    Google Scholar 

  • Goldstein, A., 1976, Opioid peptides (endorphins) in pituitary and brain, Science 193: 1081.

    Article  Google Scholar 

  • Goldstein, A., and Cox, B. M., 1977, Opioid peptides (endorphins) in pituitary and brain, Psychoneuroendocrinology 2: 11.

    Article  Google Scholar 

  • Goodwin, F. K., and Extein, I. L., 1979, The biological basis of affective disorders, in Progress in the Functional Psychoses (R. Cancro, L. Sheyer, and M. Kesselman, eds.), pp. 129-252, Spectrum Publishers, New York.

    Google Scholar 

  • Guidotti, A., and Grandison, L., 1979, Participation of endorphins in the regulation of pituitary function, in Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 416-422, Macmillan Co., New York.

    Google Scholar 

  • Guillemin, R., Vargo, T., Rossier, J., Minick, S., Ling, N., Rivier, C., Vale, W., and Bloom, F. E., 1977, ß-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland, Science 197: 1367.

    Google Scholar 

  • Gunne, L. M., Lindström, L., and Terenius, L., 1977, Naloxone-induced reversal of schizophrenic hallucinations, J. Neural Transm. 40: 13.

    Article  Google Scholar 

  • Haertzen, C. A., and Hooks, N. T., Jr., 1969, Changes in personality and subjective experience associated with the chronic administration and withdrawal of opiates, J. Nerv. Ment. Dis. 148: 606.

    Article  Google Scholar 

  • Hamilton, M., 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry. 23: 56.

    Article  Google Scholar 

  • Ho., W. K., Wen, H. L., and Fung, K. P., 1977, Comparison of plasma hormonal levels between heroin addicted and normal subjects, Clin. Chim. Acta 75: 415.

    Article  Google Scholar 

  • Holaday, J. W., and Loh, H. H., 1979, Endorphin—opiate interactions with neuroendocrine systems, in Neurochemical Mechanisms of Opiate Ligands (H. H. Loh and D. H. Ross, eds.), Advances in Biochemical Psychopharmacology, Vol. 20, pp. 227–257, Raven Press, New York.

    Google Scholar 

  • Holaday, J. W., Law, P. Y., Tseng, L. G., Loh, H. H., and Li, C. H., 1977, ß-Endorphin: Pituitary and adrenal glands modulate its action, Proc. Natl. Acad. Sci. USA 74: 4628.

    Google Scholar 

  • Hughes, J., Smith, T. W., Kosterlitz, H., Fothergill, L. A., Morgan, B. A., and Morris, H. R., 1975, Identification of two related pentapetides from the brain with potent opiate agonist activity, Nature (London) 258: 577.

    Article  Google Scholar 

  • Iwamoto, E. T., and Way, E. L., 1979, Opiate actions and catecholamines, in Neurochemical Mechanisms of Opiates and Endorphins (H. H. Loh and D. H. Ross, eds.), Advances in Biochemical Psychopharmacology, Vol. 20, pp. 357–407, Raven Press, New York.

    Google Scholar 

  • Jaffe, J. H., and Martin, W. R., 1975, Narcotic analgesics and antagonists, in The Pharmacological Basis of Therapeutics (L. S. Goodman and A. Gilman, eds.), pp. 245-283, Macmillan Co., New York.

    Google Scholar 

  • Janowsky, D. S., Judd, L. L., Huey, L. Y., Roitman, N., Parker, D., and Segal, D. S., 1978, Naloxone effects on manic symptoms and growth hormone levels, Lancet 2: 320.

    Article  Google Scholar 

  • Janowsky, D. S., Judd, L. L., Huey, L. Y., and Segal, D. S., 1979, Effects of naloxone in normal, manic and schizophrenic patients: Evidence for alleviation of manic symptoms, in Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 435-447, Macmillan Co., New York.

    Google Scholar 

  • J¢rgensen, A., Fog, R., and Veilis, B., 1979, Synthetic enkephalin analogue in treatment of schizophrenia, Lancet 1: 935.

    Google Scholar 

  • Judd, L. L., Janowsky, D. S., Segal, D. S., and Huey, L. Y., 1980, Naloxone-induced behavioral and physiological effects in normal and manic subjects, Arch. Gen. Psychiatry. 37: 583.

    Article  Google Scholar 

  • Kalin, N.H., Risch, S.C., Cohen, R. M., Insel, T., and Murphy, D. L. 1980, Dexamethasone fails to suppress ß-endorphin plasma concentrations in humans and rhesus monkeys, Science 209: 827.

    Article  Google Scholar 

  • Kline, N. S., and Lehmann, H. E., 1979, ß-Endorphin therapy in psychiatric patients, in Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 500-517, Macmillan Co., New York.

    Google Scholar 

  • Kline, N. S., Li, C. H., Lehmann, H. E., Lajtha, A., Laski, E., and Cooper, T., 1977, (ß-Endorphin induced changes in schizophrenic and depressed patients, Arch. Gen. Psychiatry. 34: 1111.

    Google Scholar 

  • Labrie, F., Dupont, A., Cusan, L., Lissitzky, J. C., Lepine, J., Raymond, V., and Coy, D. H., 1979, Effects of endorphins and their analogues on prolactin and growth hormone secretion, in Endorphins in Mental Health Research (E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.),pp. 335-343, Macmillan Co., New York.

    Google Scholar 

  • Lehmann, H. E., Ananth, J. V., Geagea, K. C., and Ban, T. A., 1971, Treatment of depression with Dexedrine and Demerol, Curr. Ther. Res. 13: 42.

    Google Scholar 

  • Lehmann, H., Vasavan Nair, N. P., and Kline, N. S., 1979, ß-Endorphin and naloxone in psychiatric patients: Clinical and biological effects, Am. J. Psychiatry 136: 762.

    Google Scholar 

  • Li, C. H., and Chung, D., 1976, Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands, Proc. Natl. Acad. Sci. USA 73: 1145.

    Article  Google Scholar 

  • Li, C. H., Chung, D., and Doneen, B. A., 1976, Isolation characterization and opiate activity of beta-endorphin from human pituitary glands, Biochem. Biophys. Res. Commun. 72: 1542.

    Article  Google Scholar 

  • Lindström, L. H., Widerlöv, E., Gunne, L. -M., Wahlström, A., and Terenius, L., 1978, Endorphins in human cerebrospinal fluid: Clinical correlations to some psychotic states, Acta Psychiatr. Scand. 57: 153.

    Google Scholar 

  • Lord, J. A., Waterfield, A. A., Hughes, J., and Kosterlitz, H. W., 1977, Endogenous opioid peptides: Multiple agonists and receptors, Nature (London) 267: 495.

    Article  Google Scholar 

  • Mains, R. E., Eipper, B. A., and Ling, N., 1977, Common precursor to corticotropins and endorphins, Proc. Natl. Acad. Sci. USA 74: 3014.

    Article  Google Scholar 

  • Martin, W. R., Jasinski, D. R., Haertzen, C. A., Kay, D. C., Jones, B. E., Mansky, P. A., and Carpenter, R. W., 1973, Methadone—A re-evaluation, Arch. Gen. Psychiatry. 28: 286.

    Article  Google Scholar 

  • Meyer, R. E., Schildkraut, J. J., Mirin, S. M., Orsulak, P. J., Randall, M., McDougle, M., Platz, P. A., Grab, E., and Babor, T., 1978, Opiates, catecholamines, behavior and mood, Psychopharmacologia. 56: 327.

    Article  Google Scholar 

  • Mirin, S. M., Meyer, R. E., and McNamee, H. B., 1976, Psychopathology and mood during heroin abuse: Acute vs. chronic effects, Arch. Gen. Psychiatry. 33: 1503.

    Article  Google Scholar 

  • Murphy, D. L., Campbell, I. C., and Costa, J. L., 1978, Current status of the indoleamine hypothesis of the affective disorders, in Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killam, eds.), pp. 1249-1260, Raven Press, New York.

    Google Scholar 

  • Naber, D., Pickar, D., Davis, G. C., Cohen, R. M., Jimerson, D. C., Elchisak, M. A., DeFraites, E. G., Kalin, N. H., and Buchsbaum, M. S., 1980a, Naloxone effects on ß-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers, Psychopharmacology 74: 125.

    Article  Google Scholar 

  • Naber, D., Pickar, D., Dionne, R. A., Bowie, D. L., Ewels, B. A., Moody, T. W., Soble, M. G., and Pert, C. G., 1980b, Assay of endogenous opiate receptor ligands in human CSF and plasma, Substance and Alcohol Actions/Misuse 1: 85.

    Google Scholar 

  • Naber, D., Pickar, D., Post, R. M., van Kammen, D. P., Waters, R. N., Ballinger, J. C., Goodwin, F. K., and Bunney, W. E., Jr., 1981, Endogenous opioid receptor ligands and ß-endorphin-immunoreactivity in CSF of psychiatric patients and normal volunteers, Am. J. Psychiatry 138: 1457.

    Google Scholar 

  • Overall, J. E., and Gorham, D. R., 1962, The brief psychiatric rating scale, Psychol. Rep. 10: 799.

    Google Scholar 

  • Pert, C. B., and Garland, B. L., 1978, The mechanism of opiate agonist and antagonist action, in Hormone Receptors, Vol. II (L. Birnbaum and B. W. O’Malley, eds.),pp. 535-549, Academic Press, New York.

    Google Scholar 

  • Pert, C. B., and Snyder, S. H., 1973, Opiate receptor: Demonstration in nervous tissue, Science 179: 1011.

    Article  Google Scholar 

  • Pickar, D., Cutler, N. R., Naber, D., Post, R. M., Pert, C. B., and Bunney, W. E., Jr., 1980, Plasma opioid activity and manic-depressive illness, Lancet 1: 937.

    Article  Google Scholar 

  • Pickar, D., Davis, G. C., Schulz, S. C., Extein, I., Wagner, R., Naber, D., Gold, P. W., van Kammen, D. P., Goodwin, F. K., Waytt, R. J., Li, C. H., and Bunney, W. E., Jr., 1981, Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed subjects, Am. J. Psychiatry 138: 160.

    Google Scholar 

  • Reichard, J. D., 1947, Addiction: Some theoretical considerations as to its nature, cause, prevention and treatment, Am. J. Psychiatry. 103: 721.

    Google Scholar 

  • Rolandi, E., and Barreca, T., 1978, Effects of two analgesic opiates (methadone and pentazocine) on the serum prolactin levels in breast cancer, Acta Endocrinol. (Copenhagen) 88: 452.

    Google Scholar 

  • Rossier, J., French, E., Guillemin, R., and Bloom, F. E., 1980, On the mechanisms of the simultaneous release of immunoreactive ß-endorphin, ACTH and prolactin by stress, in Neural Peptides and Neuronal Communication (E. Costa and M. Trabucchi, eds.), pp. 363-376, Raven Press, New York.

    Google Scholar 

  • Rubin, P., Swezey, S., and Blaschke, T., 1979, Naloxone lowers plasma prolactin in man, Lancet 1: 1293.

    Article  Google Scholar 

  • Sachar, E. J., Hellman, L., Roffwarg, H. P., Halpern, F. S., Fukushima, D. K., and Gallagher, T. F., 1973, Disrupted 24 hour patterns of cortisol secretion in psychotic depression, Arch. Gen. Psychiatry. 28: 19.

    Article  Google Scholar 

  • Sachar, E. J., Asnis, G., Nathan, R. S., Halbreich, U., Tabriz, M. A., and Halpern, F. S., 1980, Dextroamphetamine and cortisol in depression: Morning plasma cortisol levels suppressed, Arch. Gen. Psychiatry. 37: 755.

    Article  Google Scholar 

  • Savit, R. A., 1954, Extramural psychoanalytic treatment of a case of narcotic addiction, Am. J. Psychiatry. 2: 494.

    Google Scholar 

  • Schildkraut, J. J., 1978, Current status of the catecholamine hypothesis of affective disorders, in Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killam), pp. 1235-1248, Raven Press, New York.

    Google Scholar 

  • Schlesser, M. A., Winokur, G., and Sherman, B. M., 1979, Genetic subtypes of unipolar primary depressive illness distinguished by hypothalamic—pituitary—adrenal axis activity, Lancet 1: 739.

    Article  Google Scholar 

  • Schiesser, M. A., Winokur, G., and Sherman, B. M., 1980, Hypothalamic—pituitary—adrenal axis activity in depressive illness: Its relationship to classification, Arch. Gen. Psychiatry 37: 737.

    Article  Google Scholar 

  • Schulz, S. C., Wagner, R., van Kammen, D. P., Rogol, A. D., Davis, G. C., Wyatt, R. S., Pickar, D., and Bunney, W. E., Jr., 1980, Prolactin response to ß-endorphin in man, Life Sci., 27: 1735.

    Article  Google Scholar 

  • Segal, D. S., Browne, R. G., Bloom, F., Ling, N., and Guillemin, R., 1977, ß-Endorphin: Endogenous opiate or neuroleptic?, Science 198: 411.

    Google Scholar 

  • Simantov, R., and Snyder, S. H., 1977, Opiate receptor binding in the pituitary gland, Brain Res. 124: 198.

    Article  Google Scholar 

  • Simon, E. J., Hiller, J. M., and Edelman, I., 1973, Stereospecific binding of the potent narcotic analgesic [3H]etorphine to rat-brain homogenate, Proc. Natl. Acad. Sci. USA 70: 1947.

    Google Scholar 

  • Snyder, S. H., 1978, The opiate receptor and morphine-like peptides in the brain, Am. J. Psychiatry. 135: 645.

    Google Scholar 

  • Stubbs, W. A., Jones, A., Edwards, C. R. W., DeLitala, G., Jeffcoate, W. J., Ratter, S. J., Besser, G. M., Bloom, S. R., and Alberti, K. G. M. M., 1978, Hormonal and metabolic responses to an enkephalin analogue in normal man, Lancet 2: 1225.

    Article  Google Scholar 

  • Terenius, L., Wahlström, A., and Agren, H., 1977, Naloxone (Narcan) treatment in depression: Clinical observations and effects on CSF endorphins and monoamine metabolites, Psychopharmacologia. 54: 31.

    Google Scholar 

  • Tolis, G., Hickey, J., and Guyda, H., 1975, Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man, J. Clin. Endocrinol. Metab. 41: 797.

    Google Scholar 

  • Tolis, G., Dent, R., and Guyda, H., 1978, Opiates, prolactin, and the dopamine receptor, J. Clin. Endocrinol. Metab. 47: 200.

    Google Scholar 

  • Usdin, E., Bunney, W. E., Jr., and Kline, N. S. (eds.), 1979, Endorphins in Mental Health Research, Macmillan Co., New York.

    Google Scholar 

  • Verebey, K., Volavka, J., and Clouet, D., 1978, Endorphins in psychiatry: An overview and a hypothesis, Arch. Gen. Psychiatry 35: 877.

    Article  Google Scholar 

  • Volavka, J., Bauman, J., Pevnick, J., Reker, D., James, B., and Cho, D., 1981, Short-term hormonal effects of naloxone in man, Psychoneuroendocrinology 5: 225.

    Article  Google Scholar 

  • Wieder, H., and Kaplan, E. H., 1969, Drug use in adolescents: Psychodynamic meaning and pharmacogenic effect, Psychoanal. Study Child 24: 399.

    Google Scholar 

  • Wikler, A., 1952, A psychodynamic study of a patient during experimental self-regulated readdiction to morphine, Psychoanal. Q. 26: 270.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Plenum Publishing Corporation

About this chapter

Cite this chapter

Pickar, D., Extein, I., Gold, P.W., Summers, R., Naber, D., Goodwin, F.K. (1982). Endorphins and Affective Illness. In: Shah, N.S., Donald, A.G. (eds) Endorphins and Opiate Antagonists in Psychiatric Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1119-5_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1119-5_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1121-8

  • Online ISBN: 978-1-4684-1119-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics